Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease
- 1 August 2006
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (17), 5154-5161
- https://doi.org/10.1021/jm060207o
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) main protease (M(pro)), a protein required for the maturation of SARS-CoV, is vital for its life cycle, making it an attractive target for structure-based drug design of anti-SARS drugs. The structure-based virtual screening of a chemical database containing 58,855 compounds followed by the testing of potential compounds for SARS-CoV M(pro) inhibition leads to two hit compounds. The core structures of these two hits, defined by the docking study, are used for further analogue search. Twenty-one analogues derived from these two hits exhibited IC50 values below 50 microM, with the most potent one showing 0.3 microM. Furthermore, the complex structures of two potent inhibitors with SARS-CoV M(pro) were solved by X-ray crystallography. They bind to the protein in a distinct manner compared to all published SARS-CoV M(pro) complex structures. They inhibit SARS-CoV M(pro) activity via intensive H-bond network and hydrophobic interactions, without the formation of a covalent bond. Interestingly, the most potent inhibitor induces protein conformational changes, and the inhibition mechanisms, particularly the disruption of catalytic dyad (His41 and Cys145), are elaborated.Keywords
This publication has 19 references indexed in Scilit:
- From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virusBioorganic & Medicinal Chemistry Letters, 2006
- Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesPLoS Biology, 2005
- “Teaching old drugs to kill new bugs”: structure-based discovery of anti-SARS drugsBiochemical and Biophysical Research Communications, 2004
- Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLproBiochemistry, 2004
- Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore PointsJournal of Chemical Information and Computer Sciences, 2004
- Sabadinine: A Potential Non-Peptide Anti-Severe Acute-Respiratory-Syndrome Agent Identified Using Structure-Aided DesignJournal of Medicinal Chemistry, 2004
- Identifying inhibitors of the SARS coronavirus proteinaseBioorganic & Medicinal Chemistry Letters, 2003
- Structure-Based design of nonpeptide inhibitors of interleukin-1β converting enzyme (ICE, Caspase-1)Bioorganic & Medicinal Chemistry, 2002
- MOLREP: an Automated Program for Molecular ReplacementJournal of Applied Crystallography, 1997
- Cysteine proteases of positive strand RNA viruses and chymotrypsin‐like serine proteasesFEBS Letters, 1989